Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Decodon is a bioinformatics company specializing in the development of advanced image analysis software for proteomics research. The company's flagship product, Delta2D, is a leading solution for the analysis of 2D gel electrophoresis images, enabling researchers to perform precise protein expression profiling. By utilizing sophisticated image warping and registration algorithms, Decodon's technology allows for the reliable comparison of multiple gel images, significantly reducing the complexity of large-scale proteomic studies. Based in Greifswald, Germany, the company serves academic and industrial laboratories worldwide, facilitating discoveries in biomarker identification and drug development. Their solutions are designed to integrate seamlessly into laboratory workflows, providing high-performance data visualization and statistical analysis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Decodon.